These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18452381)

  • 1. Patent foramen ovale percutaneous closure: the no-implant approach.
    Butera G; Romagnoli E; Sangiorgi G; Caputi L; Chessa M; Carminati M
    Expert Rev Med Devices; 2008 May; 5(3):317-21. PubMed ID: 18452381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience.
    Sievert H; Fischer E; Heinisch C; Majunke N; Roemer A; Wunderlich N
    Circulation; 2007 Oct; 116(15):1701-6. PubMed ID: 17893276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients.
    Sievert H; Ruygrok P; Salkeld M; Baumgartner H; Meier B; Windecker S; Juliard JM; Aubry P; Tiefenbacher C; Krumsdorf U; Vermeersch P; Ewert P; Piéchaud JF
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):368-73. PubMed ID: 19133667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
    Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
    Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
    Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique.
    Majunke N; Baranowski A; Zimmermann W; Heinisch C; Wilson N; Robertson G; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):376-82. PubMed ID: 19085919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HELEX Septal Occluder for transcatheter closure of patent foramen ovale: multicentre experience.
    Billinger K; Ostermayer SH; Carminati M; Degiovanni JV; Ewert P; Hess J; Maymone-Martins FA; Qureshi SA; Salmon AP; Schneider M; Wilson N; Sievert H
    EuroIntervention; 2006 Feb; 1(4):465-71. PubMed ID: 19755222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous closure of patent foramen ovale in young patients with cryptogenic stroke: long-term follow-up].
    Mazuelos F; Suárez de Lezo J; Pan M; Mesa D; Delgado M; Ruiz M; Ojeda S; Esteban F
    Rev Esp Cardiol; 2008 Jun; 61(6):640-3. PubMed ID: 18570787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Percutaneous closure of patent foramen ovale: a wise approach].
    Gaspardone A; Iani C; Papa M
    G Ital Cardiol (Rome); 2008 Sep; 9(9):593-602. PubMed ID: 18783080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent foramen ovale closure by radiofrequency thermal coaptation: first experience in the porcine model and healing mechanisms over time.
    Hara H; Jones TK; Ladich ER; Virmani R; Auth DC; Eichinger JE; Sommer RJ; Van Tassel RA; Schwartz RS
    Circulation; 2007 Aug; 116(6):648-53. PubMed ID: 17664371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early post-procedural migraine attack predicts migraine resolution after patent foramen ovale transcatheter closure.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Braggion G; Giordan M; Chinaglia M
    Minerva Cardioangiol; 2008 Oct; 56(5):461-5. PubMed ID: 18813181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation following device closure of patent foramen ovale.
    Burow A; Schwerzmann M; Wallmann D; Tanner H; Sakata T; Windecker S; Meier B; Delacrétaz E
    Cardiology; 2008; 111(1):47-50. PubMed ID: 18239392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
    Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
    Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of contemporary devices used for transcatheter patent foramen ovale closure.
    Spies C; Reissmann U; Timmermanns I; Schräder R
    J Invasive Cardiol; 2008 Sep; 20(9):442-7. PubMed ID: 18762672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.